Hot Investor Mandate: Europe VC Firm Invests Across Therapeutics, Medical Devices, and Diagnostics Companies in All Indications

14 Mar

The firm was founded in 2017 and has multiple offices in Europe. The firm makes venture investments across the life science sector from a €100 million fund.  The firm invests throughout Europe, with a focus on the Nordic region and Western Europe; initial investments are typically €4-6 million. The firm prefers to act as a lead investor, but may consider following on as part of a strong syndicate.

The firm invests across the life science sector, including therapeutics, devices and diagnostics.  The firm only invests in products that are subject to regulation.  The firm will consider any indication or modality. The firm prefers to invest in assets that are at least ready to go into clinical trials.

The firm focuses on assets that they consider to have below the average risk level of their peer group.  The firm prefers to lead investments, particularly in its home region, and performs their own due diligence even in cases in which they act as a co-investor.  While the firm does not exclude any areas of opportunity, there is a focus on de-risked assets and areas in which the execution and regulatory risk for the asset is reduced.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: